These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31897805)

  • 41. In Vitro-In Vivo Predictive Dissolution-Permeation-Absorption Dynamics of Highly Permeable Drug Extended-Release Tablets via Drug Dissolution/Absorption Simulating System and pH Alteration.
    Li ZQ; Tian S; Gu H; Wu ZG; Nyagblordzro M; Feng G; He X
    AAPS PharmSciTech; 2018 May; 19(4):1882-1893. PubMed ID: 29663288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dissolution testing of acetylsalicylic acid by a channel flow method-correlation to USP basket and intrinsic dissolution methods.
    Peltonen L; Liljeroth P; Heikkilä T; Kontturi K; Hirvonen J
    Eur J Pharm Sci; 2003 Aug; 19(5):395-401. PubMed ID: 12907290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mini-tablets as technological strategy for modified release of morphine sulfate.
    Silva RTCE; Bruschi ML
    Pharm Dev Technol; 2022 Sep; 27(7):766-772. PubMed ID: 36017971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation and selection of bio-relevant dissolution media for a poorly water-soluble new chemical entity.
    Tang L; Khan SU; Muhammad NA
    Pharm Dev Technol; 2001 Nov; 6(4):531-40. PubMed ID: 11775954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a Clinically Relevant Dissolution Method for Metaxalone Immediate Release Formulations Based on an IVIVC Model.
    Vuletić L; Khan MZI; Špoljarić D; Radić M; Cetina-Čižmek B; Filipović-Grčić J
    Pharm Res; 2018 Jun; 35(8):163. PubMed ID: 29934663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a Dissolution Method for Gliclazide Modified-Release Tablets Using USP Apparatus 3 with in Vitro-in Vivo Correlation.
    Bezerra KC; Pinto EC; Cabral LM; de Sousa VP
    Chem Pharm Bull (Tokyo); 2018; 66(7):701-707. PubMed ID: 29962453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of critical formulation and processing variables for metoprolol tartrate extended-release (ER) matrix tablets.
    Rekhi GS; Nellore RV; Hussain AS; Tillman LG; Malinowski HJ; Augsburger LL
    J Control Release; 1999 Jun; 59(3):327-42. PubMed ID: 10332064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ranking in Vitro Dissolution of Inhaled Micronized Drug Powders including a Candidate Drug with Two Different Particle Sizes.
    Franek F; Fransson R; Thörn H; Bäckman P; Andersson PU; Tehler U
    Mol Pharm; 2018 Nov; 15(11):5319-5326. PubMed ID: 30299965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of sinkers on coning issues exhibited by tablets in USP2 dissolution apparatus.
    Terashima H; Ozeki T
    Int J Pharm; 2024 Jun; 659():124236. PubMed ID: 38768693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation of the potential for direct compaction of a fine ibuprofen powder dry-coated with magnesium stearate.
    Qu L; Zhou QT; Gengenbach T; Denman JA; Stewart PJ; Hapgood KP; Gamlen M; Morton DA
    Drug Dev Ind Pharm; 2015 May; 41(5):825-37. PubMed ID: 24738790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discriminative Dissolution Method Using the Open-Loop Configuration of the USP IV Apparatus to Compare Dissolution Profiles of Metoprolol Tartrate Immediate-Release Tablets: Use of Kinetic Parameters.
    Solis-Cruz B; Hernandez-Patlan D; Morales Hipólito EA; Tellez-Isaias G; Alcántara Pineda A; López-Arellano R
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abuse Deterrent Immediate Release Egg-Shaped Tablet (Egglets) Using 3D Printing Technology: Quality by Design to Optimize Drug Release and Extraction.
    Nukala PK; Palekar S; Patki M; Patel K
    AAPS PharmSciTech; 2019 Jan; 20(2):80. PubMed ID: 30645704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of floating and sticking extended release delivery systems: an unconventional dissolution test.
    Dürig T; Fassihi R
    J Control Release; 2000 Jun; 67(1):37-44. PubMed ID: 10773327
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models.
    Uebbing L; Klumpp L; Webster GK; Löbenberg R
    Drug Des Devel Ther; 2017; 11():1163-1174. PubMed ID: 28442890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters?
    Salwan AJ; Hagemeier NE; Harirforoosh S
    Clin Drug Investig; 2018 Jul; 38(7):573-577. PubMed ID: 29651781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of dissolution media pH and USP1 basket speed on erosion and disintegration characteristics of immediate release metformin hydrochloride tablets.
    Desai D; Wong B; Huang Y; Tang D; Hemenway J; Paruchuri S; Guo H; Hsieh D; Timmins P
    Pharm Dev Technol; 2015; 20(5):540-5. PubMed ID: 24621340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dissolution testing of modified release products with biorelevant media: An OrBiTo ring study using the USP apparatus III and IV.
    Reppas C; Vrettos NN; Dressman J; Andreas CJ; Miyaji Y; Brown J; Etherson K; Hanley S; Karkossa F; Karlsson E; Klein S; Maier GM; McAllister M; Mistry N; Rosenblatt K; Schäfer KJ; Smith KL; Tomaszewska I; Williams J; Winge F; Vertzoni M
    Eur J Pharm Biopharm; 2020 Nov; 156():40-49. PubMed ID: 32882421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of pantoprazole formulations in different dissolution apparatus using biorelevant medium.
    de Campos DR; Klein S; Zoller T; Vieria NR; Barros FA; Meurer EC; Coelho EC; Marchioretto MA; Pedrazzoli J
    Arzneimittelforschung; 2010; 60(1):42-7. PubMed ID: 20184226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extended release pellets prepared by hot melt extrusion technique for abuse deterrent potential: Category-1 in-vitro evaluation.
    Butreddy A; Sarabu S; Dumpa N; Bandari S; Repka MA
    Int J Pharm; 2020 Sep; 587():119624. PubMed ID: 32653597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the coat quality of sustained release pellets by individual pellet dissolution methodology.
    Xu M; Liew CV; Heng PWS
    Int J Pharm; 2015 Jan; 478(1):318-327. PubMed ID: 25435182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.